iPSC-MSCs Combined with Low-Dose Rapamycin Induced Islet Allograft Tolerance Through Suppressing Th1 and Enhancing Regulatory T-Cell Differentiation.
about
Mesenchymal stem cells and immunomodulation: current status and future prospectsTherapeutic effects of human gingiva-derived mesenchymal stromal cells on murine contact hypersensitivity via prostaglandin E2-EP3 signaling.Induced Pluripotent Stem Cells: A New Frontier for Stem Cells in Dentistry.Human iPSC-MSC-Derived Xenografts Modulate Immune Responses by Inhibiting the Cleavage of Caspases.Pluripotent Stem Cells as a Robust Source of Mesenchymal Stem Cells.Mesenchymal stromal cells with enhanced therapeutic properties.Rapamycin Augments Immunomodulatory Properties of Bone Marrow-Derived Mesenchymal Stem Cells in Experimental Autoimmune Encephalomyelitis.Kindlin-2 Modulates the Survival, Differentiation, and Migration of Induced Pluripotent Cell-Derived Mesenchymal Stromal CellsDurable Control of Autoimmune Diabetes in Mice Achieved by Intraperitoneal Transplantation of "Neo-Islets," Three-Dimensional Aggregates of Allogeneic Islet and "Mesenchymal Stem Cells".Immunosuppressive Mesenchymal Stromal Cells Derived from Human-Induced Pluripotent Stem Cells Induce Human Regulatory T Cells In Vitro and In Vivo.Recombinant IL-33 prolongs leflunomide-mediated graft survival by reducing IFN-γ and expanding CD4(+)Foxp3(+) T cells in concordant heart transplantation.Rap1 deficiency-provoked paracrine dysfunction impairs immunosuppressive potency of mesenchymal stem cells in allograft rejection of heart transplantation.Potential of iPSC-Derived Mesenchymal Stromal Cells for Treating Periodontal Disease.
P2860
Q26770191-E108DFBC-457B-4BB9-83B1-D99452F1871CQ37144766-AA6BE91F-D10B-4228-B4F1-1E243AEA0DA8Q38569134-149BFE43-725A-4BEC-8C61-AF5DD38CD9F2Q38777407-6B567B39-BF9A-46D8-A37A-D0C389E04701Q38999248-B1CCE96C-3C01-4D82-8BD3-8F0AB2B0CD6DQ39045625-44656322-92A2-4F8D-8D4B-B44A2773E362Q40757812-E4AEA35C-29A1-43F0-BC38-5943EA334638Q42158332-FC1F0663-458F-4FC5-AD4C-9DE5A2DF0B15Q47096061-45B9E30F-0832-4569-A549-BA774519EF0EQ49289725-04ED611F-C46C-422B-9981-CB0E648866C9Q51705716-9A8B86E9-02CE-4CF9-A414-E6E6EAF5A3D1Q52668551-CE35F88C-24AC-481F-93AF-70AB86DE2E91Q55091774-F6068776-951E-40DD-AD53-C1CB986E391E
P2860
iPSC-MSCs Combined with Low-Dose Rapamycin Induced Islet Allograft Tolerance Through Suppressing Th1 and Enhancing Regulatory T-Cell Differentiation.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
iPSC-MSCs Combined with Low-Do ...... latory T-Cell Differentiation.
@ast
iPSC-MSCs Combined with Low-Do ...... latory T-Cell Differentiation.
@en
type
label
iPSC-MSCs Combined with Low-Do ...... latory T-Cell Differentiation.
@ast
iPSC-MSCs Combined with Low-Do ...... latory T-Cell Differentiation.
@en
prefLabel
iPSC-MSCs Combined with Low-Do ...... latory T-Cell Differentiation.
@ast
iPSC-MSCs Combined with Low-Do ...... latory T-Cell Differentiation.
@en
P2093
P2860
P50
P356
P1476
iPSC-MSCs Combined with Low-Do ...... latory T-Cell Differentiation.
@en
P2093
Jia-Zhao Fu
Lu-Min Wang
Lu-Xi Meng
Pan-Pan Cheng
Peng-Fei Ma
P2860
P304
P356
10.1089/SCD.2014.0488
P577
2015-05-18T00:00:00Z